In addition, SFN suppressed the growth of KPL-1 human breast cancer cells both in vitro and in athymic mice [171], and the anti-metastatic action of SFN might be through inhibiting MMP-9 expression via the NF-κB signaling pathway [172]. The gene discussed is SFN; the disease is breast carcinoma.